Header Logo

Connection

Amir Lotfi to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Amir Lotfi has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008 May; 155(5):954-8.
    View in: PubMed
    Score: 0.249
  2. Daoulah A, Al-Faifi SM, Alhamid S, Youssef AA, Alshehri M, Al-Murayeh M, Farghali T, Maghrabi M, Balghith M, ElSayed O, Alasmari A, Arafat AA, Elmahrouk AF, Eldesoky A, Refaat WA, Alshahrani SS, Ghazi AM, Al-Azizi KM, Dahdouh Z, Lotfi A. Spontaneous Coronary Artery Dissection in the Gulf: G-SCAD Registry. Angiology. 2021 01; 72(1):32-43.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.